Skip to main content
. Author manuscript; available in PMC: 2013 Apr 18.
Published in final edited form as: Clin Rheumatol. 2011 Apr 27;30(10):1333–1339. doi: 10.1007/s10067-011-1751-0

Fig. 1.

Fig. 1

Prevalence of autoantibodies in scleroderma patients classified based on race and patterns of immunofluorescence antinuclear antibodies. ANA patterns were classified based on the dominant immunofluorescence staining pattern using 1:80 diluted sera. Patients with both anti-topo I and U1RNP were classified in anti-topo I group in this analysis